Citicoline in Vascular Cognitive Impairment: Some Latest Evidences
Open Access
- 17 July 2017
- journal article
- Published by Peertechz Publications Private Limited
- Vol. 1 (1), 018-019
- https://doi.org/10.17352/aadc.000004
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectivesClinical Interventions in Aging, 2015
- Neuroprotective Properties of Citicoline: Facts, Doubts and Unresolved IssuesCNS Drugs, 2014
- Long-Term Treatment with Citicoline May Improve Poststroke Vascular Cognitive ImpairmentCerebrovascular Diseases, 2013
- Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE studyClinical Interventions in Aging, 2013
- Citicoline in Vascular Cognitive Impairment and Vascular Dementia After StrokeStroke, 2011
- Neuroprotection and RecoveryStroke, 2011
- Citicoline, use in cognitive decline: Vascular and degenerativeJournal of the Neurological Sciences, 2010
- A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental strokeNeurobiology of Disease, 2007
- Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyEmergencias, 2005
- Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transportNeurobiology of Disease, 2005